DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31

DAVITA INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$187.00−0.31 (-0.17%)

Close on Oct 19, 2026

Market cap: $12.36B
P/E (TTM): 15.3
Dividend yield: –

Dividends

Davita has not reported a dividend

No dividend per share appears in Davita's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Davita's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Sep 30, 2013
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is DVA.

Revenue growth6.4% · median 5.5%

Operating margin15.2% · median 5.8%

Net margin6.0% · median 2.5%

Company	Revenue	Growth
THC	$21.81B	+5.4%
BTSG	$14.37B	+26.4%
DVA	$14.01B	+6.4%
AGL	$5.92B	+0.3%
PGNY	$1.31B	+5.5%
FMS	–	–

Company

Next earnings (est.): Oct 28, 2026, during market hours
Exchange: NYSE
Industry: Services-Misc Health & Allied Services, NEC
Fiscal year ends: December 31
Employees: 78,000
Held by institutions: 92.5%
Auditor: KPMG LLP
SEC CIK: 927066

Advertisement
300 × 250